6dda
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Nurr1 Covalently Modified by a Dopamine Metabolite== | |
| - | + | <StructureSection load='6dda' size='340' side='right'caption='[[6dda]], [[Resolution|resolution]] 3.20Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[6dda]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6DDA OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6DDA FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BR:BROMIDE+ION'>BR</scene>, <scene name='pdbligand=G7J:5-hydroxy-1,2-dihydro-6H-indol-6-one'>G7J</scene>, <scene name='pdbligand=K:POTASSIUM+ION'>K</scene></td></tr> | |
| - | [[Category: | + | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=OCS:CYSTEINESULFONIC+ACID'>OCS</scene></td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6dda FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6dda OCA], [http://pdbe.org/6dda PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6dda RCSB], [http://www.ebi.ac.uk/pdbsum/6dda PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6dda ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/NR4A2_HUMAN NR4A2_HUMAN]] Transcriptional regulator which is important for the differentiation and maintenance of meso-diencephalic dopaminergic (mdDA) neurons during development. It is crucial for expression of a set of genes such as SLC6A3, SLC18A2, TH and DRD2 which are essential for development of mdDA neurons (By similarity). | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Bhattacharya, P]] | ||
| + | [[Category: Boxue, T]] | ||
| + | [[Category: Bruning, J M]] | ||
| + | [[Category: England, P M]] | ||
| + | [[Category: Fletterick, R J]] | ||
| + | [[Category: Guo, S]] | ||
| + | [[Category: Holton, J M]] | ||
| + | [[Category: Jacobson, M P]] | ||
| + | [[Category: Liu, H]] | ||
| + | [[Category: Otrabella, F]] | ||
| + | [[Category: Wang, Y]] | ||
| + | [[Category: Cysteine adduct]] | ||
| + | [[Category: Dihydroxyindole]] | ||
| + | [[Category: Dopamine]] | ||
| + | [[Category: Nurr1]] | ||
| + | [[Category: Transcription]] | ||
Revision as of 07:47, 20 March 2019
Nurr1 Covalently Modified by a Dopamine Metabolite
| |||||||||||
Categories: Large Structures | Bhattacharya, P | Boxue, T | Bruning, J M | England, P M | Fletterick, R J | Guo, S | Holton, J M | Jacobson, M P | Liu, H | Otrabella, F | Wang, Y | Cysteine adduct | Dihydroxyindole | Dopamine | Nurr1 | Transcription
